3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
48
Multiple Myeloma
39
Lymphoma, Large B-Cell, Diffuse
38
Burkitt Lymphoma
34
Lymphoma
31
Leukemia, Myeloid, Acute
31
Lymphoma, Non-Hodgkin
29
Recurrence
27
Breast Neoplasms
27
Neoplasms
23
Lymphoma, B-Cell
23
Myelodysplastic Syndromes
22
Leukemia, Lymphocytic, Chronic, B-Cell
22
Lymphoma, Follicular
20
Hodgkin Disease
18
Triple Negative Breast Neoplasms
17
Melanoma
17
Leukemia
17
Ovarian Neoplasms
16
Hematologic Neoplasms
15
Neuroblastoma
14
Lymphoma, Mantle-Cell
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
12
Pancreatic Neoplasms
12
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
12
Leukemia, Biphenotypic, Acute
11
Neoplasm Metastasis
10
Lymphoma, B-Cell, Marginal Zone
10
Leukemia, Myelomonocytic, Chronic
10
Sarcoma
9
Interventions
Specimen Handling
5
Magnetic Resonance Spectroscopy
5
Cisplatin
4
trastuzumab deruxtecan
3
Platinum
3
Docetaxel
3
Carboplatin
3
Biopsy
3
pembrolizumab
2
entrectinib
2
darolutamide
2
Trastuzumab
2
Radiotherapy, Intensity-Modulated
2
Leuprolide
2
Goserelin
2
Ado-Trastuzumab Emtansine
2
1,2-diaminocyclohexaneplatinum II citrate
2
zanidatamab
1
trastuzumab biosimilar HLX02
1
sacituzumab govitecan
1
pyrotinib
1
pertuzumab
1
luprolide acetate gel depot
1
larotrectinib
1
enfortumab vedotin
1
dehydroftorafur
1
ceralasertib
1
camrelizumab
1
bicalutamide
1
apatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Salivary Gland Neoplasms
×
Cyclophosphamide
×
90 days
×
Clear all
No trials found.